News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Durrant Cameron
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/29/2022 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 808,906 options to buy
@ $0.38, valued at
$307.4k
|
|
| 03/04/2022 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Bought 40,000 shares
@ $2.34, valued at
$93.6k
|
|
| 01/14/2022 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 84,385 options to buy
@ $2.99, valued at
$252.3k
|
|
| 01/04/2022 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 76,000 options to buy
@ $3.72, valued at
$282.7k
|
|
| 11/26/2021 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Disposed/sold 17,660 options to buy
@ $5.93, valued at
$104.7k
|
|
| 10/04/2021 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 17,660 options to buy
@ $5.93, valued at
$104.7k
|
|
| 06/16/2021 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Gifted 111,441 shares
@ $0
Gifted 111,441 shares
@ $0
Sold 26,441 shares
@ $20.6, valued at
$544.7k
Sold 5,094 shares
@ $21.14, valued at
$107.7k
Sold 49,906 shares
@ $20.61, valued at
$1M
|
|
| 03/15/2021 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 652,640 options to buy
@ $16.07, valued at
$10.5M
|
|
| 10/07/2020 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 82,622 options to buy
@ $12.14, valued at
$1M
|
|
| 05/21/2020 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 250,000 options to buy
@ $0.86, valued at
$215k
|
|
| 01/29/2020 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 318,103 options to buy
@ $0.4, valued at
$127.2k
|
|
| 06/05/2019 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 8,000 shares
@ $1.25, valued at
$10k
|
|
| 05/31/2019 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Acquired 235,624 shares
@ $0 |
|
| 04/25/2019 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 75,000 shares
@ $0.665, valued at
$49.9k
Exercised 75,000 options to buy
@ $0.665, valued at
$49.9k
|
|
| 03/11/2019 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 75,000 shares
@ $0.665, valued at
$49.9k
Exercised 75,000 options to buy
@ $0.665, valued at
$49.9k
|
|
| 01/28/2019 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 142,857 options to buy
@ $0.84, valued at
$120k
|
|
| 12/14/2018 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 2,000 shares
@ $0.8219, valued at
$1.6k
Granted 4,000 shares
@ $0.816, valued at
$3.3k
|
|
| 12/12/2018 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 2,500 shares
@ $0.75, valued at
$1.9k
Granted 2,500 shares
@ $0.757, valued at
$1.9k
|
|
| 12/10/2018 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 10,000 shares
@ $0.732, valued at
$7.3k
Granted 7,000 shares
@ $0.739, valued at
$5.2k
|
|
| 03/13/2018 |
4
| Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC|
Txns:
| Granted 7,466,749 options to buy
@ $0.665, valued at
$5M
|
|
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Durrant Cameron (CEO) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 1,043,022 options to buy
@ $3.38, valued at
$3.5M
|
|
| 07/05/2016 |
4
| Durrant Cameron (Chairman and CEO) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 135,583 shares
@ $0 |
|
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/02/2016 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options
@ $0.53, valued at
$21.2k
|
|
| 01/12/2015 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options
@ $2.2, valued at
$110k
|
|
| 12/03/2014 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC|
Txns:
| Bought 4,000 shares
@ $2.5, valued at
$10k
Bought 1,000 warrants
@ $3.75, valued at
$3.8k
|
|
| 07/14/2014 |
4
| Durrant Cameron (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $3.05, valued at
$152.5k
|
|
| 04/08/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/08/2013 |
4
| Durrant Cameron (President, CEO, CFO, Treasurer) has filed a Form 4 on PediatRx Inc.|
Txns:
| Bought 4,250,000 shares
@ $0.012, valued at
$51k
|
|
| 03/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/13/2013 |
3
| Durrant Cameron (President, CEO of ECR Pharm.) has filed a Form 3 on HI TECH PHARMACAL CO INC |
| 02/11/2011 |
4
| Durrant Cameron (President, CEO) has filed a Form 4 on PediatRx Inc. |
| 02/10/2011 |
4
| Durrant Cameron (Executive Chairman) has filed a Form 4 on ANAVEX LIFE SCIENCES CORP. |
|
|
|